|
|
Сonditions and diseases
ALS Alzheimer's Disease Anemia Anti-Aging Treatment Arterial Hypertension Autism Cancer Diabetes Treatment Eye Diseases HIV/AIDS Idiopathic Encephalopathy Ischemic Heart Disease Liver Diseases MD Treatment Multiple Sclerosis Treatment Parkinson Treatment Rheumatoid Arthritis SMA Ulcerative Colitis. Crohn’s Disease
News about stem cells
Cloning Is Used to Create Embryonic Stem Cells
19 May 2013
Scientists have finally succeeded in using cloning to create human embryonic stem cells, a step toward developing replacement tissue to treat diseases.
19 May 2013
Scientists have finally succeeded in using cloning to create human embryonic stem cells, a step toward developing replacement tissue to treat diseases.
University of Adelaide research raises hope for multiple sclerosis treatment
13 May 2013
The researchers hope using stem cells from fat tissue - to send cells with anti-inflammatory properties directly to the damaged site in the central nervous system - will be able to treat the autoimmune disease.
13 May 2013
The researchers hope using stem cells from fat tissue - to send cells with anti-inflammatory properties directly to the damaged site in the central nervous system - will be able to treat the autoimmune disease.
2-year-old girl gets windpipe made from stem cells
06 May 2013
A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.
All news
06 May 2013
A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.
ALS Treatment
Amyotrophic lateral sclerosis (ALS, Charkot’s disease, Charkot’s sclerosis, in English-speaking countries – Lou Gehrig’s disease), or motor neuron disease, is a progressing illness that manifests as gradual weakening and atrophy of muscles and lasts for two to five years (in very rare cases – for seven years) with 100% fatal outcome. The clinical picture is compliant with lesion of central and peripheral motor neurons that results in bulbar syndrome as well as muscular atrophy in extremities and respiratory muscles.
Major manifestations of amyotrophic lateral sclerosis in patients include the following:
- weakness;
- muscle spasms;
- disorders of speech and swallowing;
- problems with keeping balance;
- spasticity;
- increased deep reflexes, or reflexogenic zone expansion;
- pathological reflexes;
- fibrillations;
- atrophy;
- hanging foot;
- respiratory disorders;
- paroxysms of involuntary laughter or cry;
- depression.
Treatment of ALS with stem cells
Indications for ALS treatment with stem cells include confirmed ALS diagnosis, disease progression, and lack of response to existing treatment methods. Prior to year 2000, contraindications to treatment included respiratory failure, grade III, artificial lung ventilation, dysphagia, and presence of gastric stoma. However, nowadays Cell Therapy Center EmCell has experience of treating patients with the above-mentioned complications and disorders that allows for prolonging their life by more than five years.After transplantation of fetal stem cells, 67% of ALS patients note diminishing weakness, improvement of appetite and mood, decrease in intensity of fasciculations and spasticity. Within two months after transplantation, increase of motion volume in extremities, decrease in muscular rigidity, normalization of reflexes, decrease in the number of fasciculation zones, better tolerability of daily chores, reduction in intensity of dysphagia and dysarthria (improvement of swallowing, articulation, and clarity in pronunciation of words) have been observed in 34% of patients. Stable positive clinical effect after treatment persists for three to six months.
About 48% of patients need to repeat the course of treatment during the year for retaining the attained positive results. In 25% of cases, patients need periodic transplantations of stem cells every 1.5–2 years. Duration of the ALS treatment course at Cell Therapy Center EmCell, as a rule, totals 2 days.
Transplantation of fetal stem cells does not combat the immediate cause of the disease (to date, the exact cause of disease has not been found); however, it exerts substantial influence on links of the pathological process and slows down disease progression. Transplantation of fetal stem cells improves the quality of life of ALS patients and their ability to work, and prolongs their life.
Fetal stem cells in amyotrophic lateral sclerosis (poster presentation)
English, pdf, 930 kb
Appendix
Experience of ALS treatment at Cell Therapy Center EmCellFetal stem cells in amyotrophic lateral sclerosis (poster presentation)
English, pdf, 930 kb
Patients' feedbacks
The patient F.T.G., 47 years old. Amyotrophic lateral sclerosis, cervical form, marked flaccid tetraparesisRequest info
Tweet
News and articles about ALS treatment
Transplanted neural stem cells treat ALS in mouse model
24 December 2012
In 11 independent studies, a consortium of ALS researchers shows that transplanting neural stem cells into the spinal cord of an ALS mouse model slows disease onset and progression, improves motor function, and significantly prolongs survival.
24 December 2012
In 11 independent studies, a consortium of ALS researchers shows that transplanting neural stem cells into the spinal cord of an ALS mouse model slows disease onset and progression, improves motor function, and significantly prolongs survival.
Autologous Stem Cell Trials for ALS Patients
29 July 2012
A clinical trial of stem cell therapy for ALS patients conducted by Israel-based BrainStorm Cell Therapeutics shows the treatment to be well-tolerated, safe and not presenting risk of side-effects, an interim safety review says.
29 July 2012
A clinical trial of stem cell therapy for ALS patients conducted by Israel-based BrainStorm Cell Therapeutics shows the treatment to be well-tolerated, safe and not presenting risk of side-effects, an interim safety review says.
Stem Cell Transplantation to Treat ALS Patients Proves Safe and Well-Tolerated
09 April 2012
According to the phase 1 study by Neuralstem (USA), transplantation of stem cells into the lumbar region of the spinal cord has proven safe and was well-tolerated by ALS patients who participated in the trial.
09 April 2012
According to the phase 1 study by Neuralstem (USA), transplantation of stem cells into the lumbar region of the spinal cord has proven safe and was well-tolerated by ALS patients who participated in the trial.
Improved Survival in ALS Patients with Mild Obesity
08 June 2011
The study of over 400 ALS patients conducted at Massachusetts General Hospital has shown that mildly obese patients survived longer compared to patients with normal weight, or those underweight or overweight.
All news about ALS 08 June 2011
The study of over 400 ALS patients conducted at Massachusetts General Hospital has shown that mildly obese patients survived longer compared to patients with normal weight, or those underweight or overweight.